N Volkan Adsay

Summary

Affiliation: Emory University
Country: USA

Publications

  1. ncbi Cystic neoplasia of the pancreas: pathology and biology
    N Volkan Adsay
    Department of Pathology, Emory University, Atlanta, GA 30322, USA
    J Gastrointest Surg 12:401-4. 2008
  2. ncbi Tumor budding as a strong prognostic indicator in invasive ampullary adenocarcinomas
    Nobuyuki Ohike
    Departments of Pathology, Emory University Hospital, Atlanta, GA, USA
    Am J Surg Pathol 34:1417-24. 2010
  3. ncbi Intraductal and papillary variants of acinar cell carcinomas: a new addition to the challenging differential diagnosis of intraductal neoplasms
    Olca Basturk
    Department of Pathology, Wayne State University and Karmanos Cancer Institute, Detroit, MI 48201, USA
    Am J Surg Pathol 31:363-70. 2007
  4. ncbi Differences in presentation and perioperative outcome after pancreaticoduodenectomy for cancer and benign pancreatitis
    Carrie K Chu
    Department of Surgery, Emory University School of Medicine, Atlanta, Georgia 30322, USA
    Am Surg 76:606-13. 2010
  5. ncbi DeltaNp63 expression in pancreas and pancreatic neoplasia
    Olca Basturk
    Department of Pathology, Harper University Hospital, Karmanos Cancer Institute and Wayne State University, Detroit, MI 48201, USA
    Mod Pathol 18:1193-8. 2005
  6. ncbi Intra-ampullary papillary-tubular neoplasm (IAPN): characterization of tumoral intraepithelial neoplasia occurring within the ampulla: a clinicopathologic analysis of 82 cases
    Nobuyuki Ohike
    Department of Pathology, Emory University Hospital, Atlanta, GA, USA
    Am J Surg Pathol 34:1731-48. 2010
  7. ncbi Pathogenesis of colloid (pure mucinous) carcinoma of exocrine organs: Coupling of gel-forming mucin (MUC2) production with altered cell polarity and abnormal cell-stroma interaction may be the key factor in the morphogenesis and indolent behavior of collo
    N Volkan Adsay
    Department of Pathology, Karamanos Cancer Institute and Wayne State University, Detroit, Michigan 48201, USA
    Am J Surg Pathol 27:571-8. 2003
  8. ncbi Pathologic staging of pancreatic, ampullary, biliary, and gallbladder cancers: pitfalls and practical limitations of the current AJCC/UICC TNM staging system and opportunities for improvement
    N Volkan Adsay
    Department of Pathology, Emory University, School of Medicine, Atlanta, Georgia, USA
    Semin Diagn Pathol 29:127-41. 2012
  9. ncbi The number of lymph nodes identified in a simple pancreatoduodenectomy specimen: comparison of conventional vs orange-peeling approach in pathologic assessment
    N Volkan Adsay
    Department of Pathology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA
    Mod Pathol 22:107-12. 2009
  10. ncbi Impact of diabetes mellitus on perioperative outcomes after resection for pancreatic adenocarcinoma
    Carrie K Chu
    Department of Surgery, Emory University School of Medicine, Atlanta, GA, USA
    J Am Coll Surg 210:463-73. 2010

Detail Information

Publications69

  1. ncbi Cystic neoplasia of the pancreas: pathology and biology
    N Volkan Adsay
    Department of Pathology, Emory University, Atlanta, GA 30322, USA
    J Gastrointest Surg 12:401-4. 2008
    ....
  2. ncbi Tumor budding as a strong prognostic indicator in invasive ampullary adenocarcinomas
    Nobuyuki Ohike
    Departments of Pathology, Emory University Hospital, Atlanta, GA, USA
    Am J Surg Pathol 34:1417-24. 2010
    ..Therefore, budding should be incorporated into surgical pathology reports for AAC...
  3. ncbi Intraductal and papillary variants of acinar cell carcinomas: a new addition to the challenging differential diagnosis of intraductal neoplasms
    Olca Basturk
    Department of Pathology, Wayne State University and Karmanos Cancer Institute, Detroit, MI 48201, USA
    Am J Surg Pathol 31:363-70. 2007
    ..The clinical significance of this variant is difficult to determine; however, it appears that the tumors are relatively small and metastasis at presentation is less common than typically seen in ACCs (1/7 vs. 50%)...
  4. ncbi Differences in presentation and perioperative outcome after pancreaticoduodenectomy for cancer and benign pancreatitis
    Carrie K Chu
    Department of Surgery, Emory University School of Medicine, Atlanta, Georgia 30322, USA
    Am Surg 76:606-13. 2010
    ..Infectious complication risk is higher in patients with adenocarcinoma. Increased age and jaundice should raise suspicion of cancer in patients with chronic pancreatitis undergoing evaluation for surgical treatment...
  5. ncbi DeltaNp63 expression in pancreas and pancreatic neoplasia
    Olca Basturk
    Department of Pathology, Harper University Hospital, Karmanos Cancer Institute and Wayne State University, Detroit, MI 48201, USA
    Mod Pathol 18:1193-8. 2005
    ..IV) No p63-expressing 'stem' cells are present in the pancreas...
  6. ncbi Intra-ampullary papillary-tubular neoplasm (IAPN): characterization of tumoral intraepithelial neoplasia occurring within the ampulla: a clinicopathologic analysis of 82 cases
    Nobuyuki Ohike
    Department of Pathology, Emory University Hospital, Atlanta, GA, USA
    Am J Surg Pathol 34:1731-48. 2010
    ..Here, we provide a detailed analysis of these neoplasms, which we propose to refer to as intra-ampullary papillary-tubular neoplasm (IAPN)...
  7. ncbi Pathogenesis of colloid (pure mucinous) carcinoma of exocrine organs: Coupling of gel-forming mucin (MUC2) production with altered cell polarity and abnormal cell-stroma interaction may be the key factor in the morphogenesis and indolent behavior of collo
    N Volkan Adsay
    Department of Pathology, Karamanos Cancer Institute and Wayne State University, Detroit, Michigan 48201, USA
    Am J Surg Pathol 27:571-8. 2003
    ..This distinctive mucin, accumulated in the stroma surrounding the CC cells, may act as a containing factor, slackening the spread of the cells...
  8. ncbi Pathologic staging of pancreatic, ampullary, biliary, and gallbladder cancers: pitfalls and practical limitations of the current AJCC/UICC TNM staging system and opportunities for improvement
    N Volkan Adsay
    Department of Pathology, Emory University, School of Medicine, Atlanta, Georgia, USA
    Semin Diagn Pathol 29:127-41. 2012
    ..Proper grossing and appreciation of histo-anatomic subtleties of this region are crucial in addressing these issues and achieving more applicable and clinically relevant staging systems in the future...
  9. ncbi The number of lymph nodes identified in a simple pancreatoduodenectomy specimen: comparison of conventional vs orange-peeling approach in pathologic assessment
    N Volkan Adsay
    Department of Pathology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA
    Mod Pathol 22:107-12. 2009
    ..Therefore, lymph node harvest by the orange-peeling method should be performed routinely before specimen sectioning in assessment of pancreatoduodenectomy for ductal adenocarcinoma...
  10. ncbi Impact of diabetes mellitus on perioperative outcomes after resection for pancreatic adenocarcinoma
    Carrie K Chu
    Department of Surgery, Emory University School of Medicine, Atlanta, GA, USA
    J Am Coll Surg 210:463-73. 2010
    ..Associations between diabetes mellitus (DM) and pancreatic ductal adenocarcinoma (PDAC) are well established; however, the impact of DM on perioperative morbidity and mortality after PDAC resection is unclear...
  11. ncbi Excision repair cross-complementing gene-1, ribonucleotide reductase subunit M1, ribonucleotide reductase subunit M2, and human equilibrative nucleoside transporter-1 expression and prognostic value in biliary tract malignancy
    Sarah B Fisher
    Department of Surgery, Division of Surgical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia 30322, USA
    Cancer 119:454-62. 2013
    ..The differential expression and prognostic value of these biomarkers in biliary tract malignancy (BTM) is unknown...
  12. ncbi Preoperative diabetes mellitus and long-term survival after resection of pancreatic adenocarcinoma
    Carrie K Chu
    Department of Surgery, Emory University School of Medicine, Atlanta, GA, USA
    Ann Surg Oncol 17:502-13. 2010
    ..To assess clinicopathologic features and postresection survival of diabetes mellitus (DM)-associated pancreatic ductal adenocarcinoma (PDAC)...
  13. ncbi Histopathological diagnosis of pancreatic intraepithelial neoplasia and intraductal papillary-mucinous neoplasms: interobserver agreement
    Daniel S Longnecker
    Department of Pathology, Dartmouth Hitchcock Medical Center, Lebanon, NH 03756, USA
    Pancreas 31:344-9. 2005
    ....
  14. ncbi Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray
    Anirban Maitra
    Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA
    Mod Pathol 16:902-12. 2003
    ....
  15. ncbi Positive immunohistochemical staining of KIT in solid-pseudopapillary neoplasms of the pancreas is not associated with KIT/PDGFRA mutations
    Dengfeng Cao
    Department of Pathology, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins Medical Institutions, Baltimore, MD, USA
    Mod Pathol 19:1157-63. 2006
    ....
  16. ncbi Chronic pancreatitis or pancreatic ductal adenocarcinoma?
    N Volkan Adsay
    Department of Pathology, The Karmanos Cancer Institute and Wayne State University School of Medicine, Detroit, Michigan, USA
    Semin Diagn Pathol 21:268-76. 2004
    ..Combinations of these criteria should aid in the differential diagnosis of invasive ductal adenocarcinoma from benign/reactive ducts in the pancreas...
  17. ncbi Lipomatous pseudohypertrophy of the pancreas: a clinicopathologically distinct entity
    Deniz Altinel
    Department of Pathology, Emory University, Atlanta, GA 30322, USA
    Pancreas 39:392-7. 2010
    ..As a result, benign lesions are sometimes surgically removed. One such condition, which is poorly defined in the literature, is referred to as lipomatous pseudohypertrophy (LPH) of the pancreas...
  18. ncbi Lipid-rich variant of pancreatic endocrine neoplasms
    Rajendra Singh
    Department of Pathology, Harper Hospital and Karmanos Cancer Institute, Wayne State University, Detroit, MI 48201, USA
    Am J Surg Pathol 30:194-200. 2006
    ..EM supports the name lipid-rich for this variant. The findings suggest that the pathogenesis of lipid-rich tumors may be different from the VHL-associated clear-cell variants of PENs...
  19. ncbi GLUT-1 expression in pancreatic neoplasia: implications in pathogenesis, diagnosis, and prognosis
    Olca Basturk
    Department of Pathology, New York University, New York, NY, USA
    Pancreas 40:187-92. 2011
    ..However, literature regarding the significance of GLUT-1 expression in pancreatic neoplasia has been limited and controversial...
  20. ncbi Is serous cystadenoma of the pancreas a model of clear-cell-associated angiogenesis and tumorigenesis?
    Duangpen Thirabanjasak
    Department of Pathology, Wayne State University and Karmanos Cancer Institute, Detroit, MI, USA
    Pancreatology 9:182-8. 2009
    ..Over the years, we have also noticed that the tumor epithelium shows a prominent capillary network...
  21. ncbi TNM staging of colorectal carcinoma: issues and caveats
    Jinru Shia
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    Semin Diagn Pathol 29:142-53. 2012
    ..The article also provides a brief discussion about some of the major adjunct histopathologic prognostic factors, such as medullary-type histology and tumor differentiation...
  22. ncbi Tumor characteristics and survival analysis of incidental versus suspected gallbladder carcinoma
    Laura M Mazer
    Department of Surgery, Emory University, 1364 Clifton Road, NE, Suite H 124 C, Atlanta, GA 30322, USA
    J Gastrointest Surg 16:1311-7. 2012
    ..There are scant data comparing presentation and outcome for patients with incidental versus suspected GBC. The goal of this study is to determine the clinical differences between these two entities...
  23. ncbi Tumoral and angiogenesis factors in hepatocellular carcinoma after locoregional therapy
    Alton B Farris
    Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA 30322, USA
    Pathol Res Pract 208:15-21. 2012
    ....
  24. ncbi Squamoid cyst of pancreatic ducts: A distinct type of cystic lesion in the pancreas
    Mohammad Othman
    Department of Pathology, Wayne State University and Karmanos Cancer Institute, Detroit, MI 48021, USA
    Am J Surg Pathol 31:291-7. 2007
    ..It seems to be a metaplastic cystic transformation beginning in the intercalated ducts. Although obstructive etiology is suspected, a specific factor or surrogate evidence of obstruction such as chronic pancreatitis is typically lacking...
  25. ncbi Urothelial carcinoma with villoglandular differentiation: a study of 14 cases
    Matthew Lim
    Department of Pathology, Emory University School of Medicine, 1364 Clifton Road NE, Atlanta, GA 30322, USA
    Mod Pathol 22:1280-6. 2009
    ..These relatively rare tumors should be recognized as a variant of urothelial carcinoma...
  26. ncbi Is nonsmall cell type high-grade neuroendocrine carcinoma of the tubular gastrointestinal tract a distinct disease entity?
    Jinru Shia
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Am J Surg Pathol 32:719-31. 2008
    ..These tumors are clinically aggressive. Prospective studies using defined diagnostic criteria are needed to determine their biologic characteristics and optimal management...
  27. ncbi Intraductal papillary-mucinous neoplasms of the pancreas: an analysis of in situ and invasive carcinomas in 28 patients
    N Volkan Adsay
    Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York 1002, USA
    Cancer 94:62-77. 2002
    ....
  28. ncbi The dichotomy in the preinvasive neoplasia to invasive carcinoma sequence in the pancreas: differential expression of MUC1 and MUC2 supports the existence of two separate pathways of carcinogenesis
    N Volkan Adsay
    Department of Pathology, Karmanos Cancer Institute, Detroit, Michigan, USA
    Mod Pathol 15:1087-95. 2002
    ....
  29. ncbi Expression of novel markers of pancreatic ductal adenocarcinoma in pancreatic nonductal neoplasms: additional evidence of different genetic pathways
    Dengfeng Cao
    Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, MD 21231-2410, USA
    Mod Pathol 18:752-61. 2005
    ....
  30. ncbi A proposal for a new and more practical grading scheme for pancreatic ductal adenocarcinoma
    N Volkan Adsay
    Department of Pathology, Karmanos Cancer Institute and Harper University Hospital, Wayne State University, 3990 John R Street, Detroit, MI 48201, USA
    Am J Surg Pathol 29:724-33. 2005
    ..Most importantly, it is clinically relevant with good prognostic value. Lastly, it is also applicable for use in research, by utilizing "patterns," even in small specimens like microarrays or biopsies...
  31. ncbi Pathology of genetically engineered mouse models of pancreatic exocrine cancer: consensus report and recommendations
    Ralph H Hruban
    Department of Pathology, The Sol Goldman Center for Pancreatic Cancer Research, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21231, USA
    Cancer Res 66:95-106. 2006
    ....
  32. ncbi Pathology reporting of neuroendocrine tumors: application of the Delphic consensus process to the development of a minimum pathology data set
    David S Klimstra
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Am J Surg Pathol 34:300-13. 2010
    ..Examination of the areas of disagreement reveals significant opportunities for collaborative study to resolve unanswered questions...
  33. ncbi Down-regulation of platelet-derived growth factor-D inhibits cell growth and angiogenesis through inactivation of Notch-1 and nuclear factor-kappaB signaling
    Zhiwei Wang
    Department of Pathology, Karmanos Cancer Institute, Wayne State University, 9374 Scott Hall, 540 East Canfield, Detroit, MI 48201, USA
    Cancer Res 67:11377-85. 2007
    ..e., MMP-9 and VEGF), resulting in the inhibition of invasion and angiogenesis...
  34. ncbi An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms
    Ralph H Hruban
    Department of Pathology, The Johns Hopkins Medical Institutions, 401 N Broadway, Weinberg 2242, Baltimore, MD 21231 2410, USA
    Am J Surg Pathol 28:977-87. 2004
    ..We present a consensus classification of the precursor lesions in the pancreatic ducts, PanINs and IPMNs...
  35. ncbi Giant and complicated variants of cystic bile duct hamartomas of the liver: MRI findings and pathological correlations
    Diego R Martin
    Emory University School of Medicine, Department of Radiology, Atlanta, Georgia 30322, USA
    J Magn Reson Imaging 31:903-11. 2010
    ..To describe a new category of liver cyst we propose calling "giant bile duct hamartoma (giant-BDH)" and to provide a more complete record of the magnetic resonance imaging (MRI) features of BDHs with potential for clinical impact...
  36. ncbi Important prognostic factors in adenocarcinoma of the ampulla of Vater
    Michael C Lowe
    Department of Surgery, Emory University School of Medicine, Atlanta, Georgia 30322, USA
    Am Surg 75:754-60; discussion 761. 2009
    ..N1 disease and presence of PNI demonstrated independent associations with worse survival. Given high percentage of mixed histology, PNI may be more informative than the subtype in predicting outcome for patients with AmpCA...
  37. ncbi Diagnostic features and differential diagnosis of autoimmune pancreatitis
    N Volkan Adsay
    Department of Pathology, The Karmanos Cancer Institute and Wayne State University School of Medicine, Detroit, Michigan, USA
    Semin Diagn Pathol 22:309-17. 2005
    ..It is important to recognize the distinctive clinicopathologic features of this entity, so that it can be diagnosed accurately and managed appropriately...
  38. ncbi MR imaging of cystic lesions of the pancreas
    Bobby Kalb
    Department of Radiology, Emory University School of Medicine, 1365 Clifton Rd NE, Building A, AT622, Atlanta, GA 30322, USA
    Radiographics 29:1749-65. 2009
    ..Primary cystic lesions are more common than solid neoplasms with cystic changes. Knowledge of the varied MR imaging appearances of pancreatic cystic lesions may help radiologists achieve greater specificity in diagnostic reporting...
  39. ncbi Molecular classification of neoplasms of the pancreas
    Ralph H Hruban
    Department of Pathology, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins Medical Institutions, Baltimore, MD 21231, USA
    Hum Pathol 40:612-23. 2009
    ..This classification does not ignore previous histology-based classification systems but instead embraces them, creating an integrated histological-molecular classification...
  40. ncbi The "new kid on the block": Intraductal papillary mucinous neoplasms of the pancreas: current concepts and controversies
    N Volkan Adsay
    Department of Pathology, Harper University Hospital and Wayne State University School of Medicine, Detroit, MI 48201, USA
    Surgery 133:459-63. 2003
  41. ncbi Pancreatic cysts: pathologic classification, differential diagnosis, and clinical implications
    Olca Basturk
    Department of Pathology, New York University, New York, New York, USA
    Arch Pathol Lab Med 133:423-38. 2009
    ..Consequently, in the past 2 decades, the nature of many cystic tumors in this organ has been better characterized, and significant developments have taken place in the classification and in our understanding of pancreatic cystic lesions...
  42. ncbi MUC2 expression in primary mucinous and nonmucinous adenocarcinoma of the prostate: an analysis of 50 cases on radical prostatectomy
    Adeboye O Osunkoya
    Department of Pathology, Emory University School of Medicine, Atlanta, GA 30322, USA
    Mod Pathol 21:789-94. 2008
    ....
  43. ncbi Intraductal papillary mucinous neoplasms of the pancreas: pathology and molecular genetics
    N Volkan Adsay
    Department of Pathology, Harper University Hospital and Karmanos Cancer Institute, Wayne State University, Detroit, Michigan, USA
    J Gastrointest Surg 6:656-9. 2002
  44. ncbi Secondary tumors of the pancreas: an analysis of a surgical and autopsy database and review of the literature
    N Volkan Adsay
    Department of Pathology, The Karmanos Cancer Institute and Wayne State University, Harper Hospital, 3990 John R Street, Detroit, MI 48201, USA
    Virchows Arch 444:527-35. 2004
    ..These are predominantly hematopoietic malignancies or carcinomas of renal or gastric origin. Secondary tumors should be entertained in both the clinical and pathological differential diagnosis of pancreatic neoplasia...
  45. ncbi Pathologic staging of tumors: pitfalls and opportunities for improvements
    N Volkan Adsay
    Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia, USA
    Semin Diagn Pathol 29:103-8. 2012
    ....
  46. ncbi An analysis of human equilibrative nucleoside transporter-1, ribonucleoside reductase subunit M1, ribonucleoside reductase subunit M2, and excision repair cross-complementing gene-1 expression in patients with resected pancreas adenocarcinoma: implication
    Sarah B Fisher
    Division of Surgical Oncology, Department of Surgery, Winship Cancer Institute, Emory University, Atlanta, Georgia 30322, USA
    Cancer 119:445-53. 2013
    ..To the authors's knowledge, their role in PAC is not defined...
  47. ncbi Hepatocellular carcinoma lesion characterization: single-institution clinical performance review of multiphase gadolinium-enhanced MR imaging--comparison to prior same-center results after MR systems improvements
    David J S Becker-Weidman
    Department of Radiology, Emory University School of Medicine, Atlanta, GA, USA
    Radiology 261:824-33. 2011
    ....
  48. ncbi Clinicopathologic analysis of pancreatic adenocarcinoma in African Americans and Caucasians
    Nat L Pernick
    Department of Pathology, Barbara Ann Karmanos Cancer Institute and Wayne State University School of Medicine, Detroit, USA
    Pancreas 26:28-32. 2003
    ..At the molecular level, African Americans had more frequent K- mutations to valine than did Caucasians...
  49. ncbi E-cadherin expression in plasmacytoid, signet ring cell and micropapillary variants of urothelial carcinoma: comparison with usual-type high-grade urothelial carcinoma
    Matthew G Lim
    Department of Pathology, Emory University School of Medicine, Atlanta, GA, USA
    Mod Pathol 24:241-7. 2011
    ..Loss of E-cadherin expression may be a marker of plasmacytoid and signet ring cell differentiation in urothelial carcinoma...
  50. ncbi Desmoplastic small cell tumor in the pancreas
    Tarek A Bismar
    Department of Pathology, Harper University Hospital, Wayne State University, Detroit, MI 48201, USA
    Am J Surg Pathol 28:808-12. 2004
    ..This case is also another demonstrative example of how DSCT may form a dominant mass in intraabdominal organs...
  51. ncbi Neoplastic precursors of the gallbladder and extrahepatic biliary system
    N Volkan Adsay
    Department of Pathology, Emory University School of Medicine, 1364 Clifton Road, H 180 B, Atlanta, GA 30322, USA
    Gastroenterol Clin North Am 36:889-900, vii. 2007
    ....
  52. ncbi Almost all infiltrating colloid carcinomas of the pancreas and periampullary region arise from in situ papillary neoplasms: a study of 39 cases
    Gregory Seidel
    Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
    Am J Surg Pathol 26:56-63. 2002
    ..Instead, other factors such as tumor location, perineural invasion, vascular invasion, and margin status after resection are far more important...
  53. ncbi Primary versus radiation-associated craniofacial osteosarcoma: Biologic and clinicopathologic comparisons
    Jonathan B McHugh
    Department of Pathology, University of Michigan, Ann Arbor, Michigan 48109-0054, USA
    Cancer 107:554-62. 2006
    ..In addition, they demonstrate higher expression rates of adverse prognostic indicators, further highlighting the distinction...
  54. ncbi Histopathologic assessment of pancreatic cancer: does one size fit all?
    Michelle D Reid
    Department of Pathology, Emory University School of Medicine, Atlanta, Georgia, USA
    J Surg Oncol 107:67-77. 2013
    ..Because these tumors are often combined with PDAC in research databases, it causes misleading variability in the analysis of pancreatic cancers. We examine the histopathology of a variety of pancreatic cancers...
  55. ncbi Lymphoplasmacytic sclerosing (autoimmune) pancreatitis
    David S Klimstra
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Semin Diagn Pathol 21:237-46. 2004
    ..This review presents the defining clinical and pathologic features of LPSP and discusses the ongoing efforts to understand the pathogenesis of this disease...
  56. ncbi Lymphoepithelial cysts of the pancreas: a report of 12 cases and a review of the literature
    N Volkan Adsay
    Department of Pathology, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan, USA
    Mod Pathol 15:492-501. 2002
    ..LECs are not associated with the clinical syndromes that are seen with their analogues in the salivary glands...
  57. ncbi Inactivation of Smad4 accelerates Kras(G12D)-mediated pancreatic neoplasia
    Kyoko Kojima
    Department of Microbiology, The University of Alabama at Birmingham, Birmingham, AL 35294, USA
    Cancer Res 67:8121-30. 2007
    ..This indicates that Smad4 is dispensable for normal pancreatic development but is critical for at least partial suppression of multiple Kras(G12D)-dependent disease-associated phenotypes...
  58. ncbi Pancreatic endocrine tumors with ductules
    Runjan Chetty
    Am J Surg Pathol 29:136-7; author reply 137-8. 2005
  59. ncbi Pathologically and biologically distinct types of epithelium in intraductal papillary mucinous neoplasms: delineation of an "intestinal" pathway of carcinogenesis in the pancreas
    N Volkan Adsay
    Departments of Pathology, Karmanos Cancer Institute and Wayne State University, Detroit, MI 48201, USA
    Am J Surg Pathol 28:839-48. 2004
    ....
  60. ncbi Solid-pseudopapillary tumors of the pancreas: case report and literature review
    Wesley P Francis
    Department of Surgery, Wayne State University, Detroit, Michigan 48201, USA
    Curr Surg 63:469-72. 2006
    ..The patient underwent complete excision of the tumor and had an open Roux-en-Y gastric bypass performed concurrently. The patient had an uneventful postoperative course. A review of the literature is presented...
  61. ncbi Not all "mucinous carcinomas" are equal: time to redefine and reinvestigate the biologic significance of mucin types and patterns in the GI tract
    N Volkan Adsay
    Virchows Arch 447:111-2. 2005
  62. ncbi Biliary intraepithelial neoplasia: an international interobserver agreement study and proposal for diagnostic criteria
    Yoh Zen
    Department of Human Pathology, Kanazawa University Graduate School of Medicine, Kanazawa, Japan
    Mod Pathol 20:701-9. 2007
    ..This classification should help to advance clinical and research applications...
  63. ncbi Fas and Fas ligand expression in pancreatic adenocarcinoma
    Nat L Pernick
    LLC, PathologyOutlines com
    Pancreas 25:e36-41. 2002
    ..Both proteins are expressed in most if not all pancreatic carcinoma cell lines, but their study in primary human tumors has been limited...
  64. ncbi Pancreatic pseudotumors: non-neoplastic solid lesions of the pancreas that clinically mimic pancreas cancer
    N Volkan Adsay
    Karmanos Cancer Institute Wayne State University, Detroit, Michigan, USA
    Semin Diagn Pathol 21:260-7. 2004
    ..Nonspecific terms such as "inflammatory pseudotumor" ought to be avoided, and every attempt should be made to classify a "pseudotumor" into a more specific diagnostic category discussed above...
  65. ncbi Multicystic adenomatoid hamartoma of the pancreas: a hitherto undescribed pancreatic tumor occurring in a 3-year-old boy
    Michael Thrall
    Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA
    Pediatr Dev Pathol 11:314-20. 2008
    ..quot; As a result of its superficial resemblance to Stocker type 2 cystic adenomatoid malformation of the lung, we are proposing the name "multicystic adenomatoid hamartoma" for this lesion...
  66. ncbi Role of MUC genes and mucins in pancreatic neoplasia
    N Volkan Adsay
    Am J Gastroenterol 101:2330-2. 2006
  67. ncbi Oncocytic papillary neoplasms of the biliary tract: a clinicopathological, mucin core and Wnt pathway protein analysis of four cases
    Marjan Rouzbahman
    Department of Pathology, University Health Network University of Toronto, Toronto, Canada
    Pathology 39:413-8. 2007
    ....
  68. ncbi Kras(G12D) and Smad4/Dpc4 haploinsufficiency cooperate to induce mucinous cystic neoplasms and invasive adenocarcinoma of the pancreas
    Kamel Izeradjene
    Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
    Cancer Cell 11:229-43. 2007
    ..Our findings suggest that the sequence, as well as the context, in which these critical mutations are acquired helps determine the ensuing pathology...
  69. ncbi Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies
    Christine A Iacobuzio-Donahue
    Departments of Pathology, Surgery, Oncology, and Medicine, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21205, USA
    Cancer Res 63:8614-22. 2003
    ....